6505NCM152446: ALBENDAZOLE TABLETS.
The ALBENDAZOLE TABLETS is a the manufacturer industrial component. Key specifications include administration: ORAL, primary_container_type: BOTTLE, protective_storage_feature: CONTROLLED ROOM TEMPERATURE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 2.0 TABLETS, active_medicament_medicinal_strength: 200.0 MILLIGRAMS ALBENDAZOLE ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-649-3422, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| special_features | TRADE NAME "ALBENZA"; ALBENDAZOLE TABLETS, 200MG; 2 TABLETS PER BOTTLE; STORE AT 20 TO 25 C (68 TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE) |
| primary_container_type | BOTTLE |
| protective_storage_feature | CONTROLLED ROOM TEMPERATURE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 1 |
| primary_container_content_quantity | 2.0 TABLETS |
| active_medicament_medicinal_strength | 200.0 MILLIGRAMS ALBENDAZOLE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | ALBENZA (ALBENDAZOLE) TABLETS, 200MG, 2S |
| NSN | 6505-01-649-3422 |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.0 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | TRADE NAME "ALBENZA"; ALBENDAZOLE TABLETS, 200MG; 2 TABLETS PER BOTTLE; STORE AT 20 TO 25 C (68 TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE) |
| PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ALBENZA (ALBENDAZOLE) TABLETS, 200MG, 2S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 200.0 MILLIGRAMS ALBENDAZOLE ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 1 |